Company / Interest Expense per Share
Caris Life Sciences, Inc. Interest Expense per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$1.56
FY2025
5-year range
$0.90 / $1.56
FY2023-FY2025
Trend
+10.5%
vs FY2024
Sector context
#13 of 46
Health Care
What the data says
At $1.56, Caris Life Sciences, Inc.'s interest expense per share ranks #34 of 46 in the Health Care sector. Increased from $0.90 to $1.56 over the past 2 years.
Based on SEC 10-K filings.
1.56 in FY2025.
Increased from $0.90 to $1.56 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#34 of 46 in Health CareTop 72% of 46This company $1.56 Sector average $1.36
▼
+14.7% above sector average
Key checks
Key Insights
- In FY2025, interest expense per share increased 10.5% year-over-year.
- Ranks #13 out of 46 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.56 | +10.5% |
| FY2024 | $1.41 | +56.0% |
| FY2023 | $0.90 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026